JMS Co., Ltd. Reports Consolidated Earnings Results for the Year Ended March 31, 2017; Provides Earnings Guidance for the Six Months Ending September 30, 2017 and Year Ending March 31, 2018
May 12, 2017
Share
JMS Co., Ltd. reported consolidated earnings results for the year ended March 31, 2017. For the quarter, the company's net sales were ¥55,574 million against ¥57,636 million a year ago. Operating income was ¥1,106 million against ¥1,422 million a year ago. Ordinary income was ¥1,451 million against of ¥1,252 million a year ago. Profit attributable to owners of parent was ¥1,182 million against ¥754 million a year ago. Rate of return on equity was 3.8% against 2.4% a year ago. Cash flows from operating activities parent was ¥4,675 million against ¥4,526 million a year ago. Profit before income taxes was ¥1,100 million against ¥1,205 million a year ago. Purchase of property, plant and equipment was ¥4,744 million against ¥6,275 million a year ago. Purchase of intangible assets was ¥98 million against ¥81 million a year ago. Net income per share was ¥24.26 against ¥15.48 a year ago.
For the six months ending September 30, 2017, the company expects net sales to be ¥28,000 million, operating income to be ¥500 million, ordinary income to be ¥500 million and profit attributable to owners of parent to be ¥300 million or ¥6.16 per basic share.
For the year ending March 31, 2018, the company expects net sales to be ¥57,000 million, operating income to be ¥1,150 million, ordinary income of ¥1,200 million and profit attributable to owners of parent to be ¥700 million or ¥28.73 per basic share.
JMS CO.,LTD. is a Japan-based company mainly engaged in the manufacture and sale of medical equipment and drugs. The Company operates through five geographical segments including Japan, Singapore, China, Philippines and Germany. The Company is engaged in the manufacture and sale of infusion and nutrition products, dialysis products, surgery products, blood and cell products and other products. The Companyâs main products include infusion & transfusion set, syringe pump, surgical gown, dialysis kit, peritoneal dialysate, microcatheter, blood bag, among others. The Company is also involved in the provision of maintenance service and other related services.
JMS Co., Ltd. Reports Consolidated Earnings Results for the Year Ended March 31, 2017; Provides Earnings Guidance for the Six Months Ending September 30, 2017 and Year Ending March 31, 2018